• Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer 

      Vrede, S.W.; van Weelden, Willem Jan; Visser, Nicole C.M.; Bulten, Johan; Van Der Putten, Louis J.M.; Van De Vijver, Koen; Santacana, Maria; Colas, Eva; Gil-Moreno, Antonio; Moiola, Cristian P.; Mancebo, Gemma; Krakstad, C.; Trovik, J.; Haldorsen, Ingfrid S.; Huvila, Jutta; Koskas, Martin; Weinberger, Vit; Bednarikova, M.; Hausnerova, Jitka; van der Wurff, der; Matias-Guiu, Xavier; Amant, Frédéric; Snijders, Marc P.L.M.; Küsters-Vandevelde, Heidi V.N.; Reijnen, Casper; Pijnenborg, Johanna M.A. (Journal article; Peer reviewed, 2021)
      Objective: Pre-operative immunohistochemical (IHC) biomarkers are not incorporated in endometrial cancer (EC) risk classification. We aim to investigate the added prognostic relevance of IHC biomarkers to the ESMO-ESGO-ESTRO ...